BioNTech Stock Options
| BNTX Stock | USD 88.09 0.40 0.45% |
BioNTech's option chain provides insight into all available option contracts written on BioNTech's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of BioNTech's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given BioNTech option contract.
In The Money vs. Out of Money Option Contracts on BioNTech
Analyzing BioNTech's in-the-money options over time can help investors to take a profitable long position in BioNTech regardless of its overall volatility. This is especially true when BioNTech's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money BioNTech's options could be used as guardians of the underlying stock as they move almost dollar for dollar with BioNTech's stock while costing only a fraction of its price.
BioNTech's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 36.25 with a put-to-call open interest ratio of 0.18 over 48 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 29, with calls trading at the volume of 263. This yields a 0.11 put-to-call volume ratio. The BioNTech option chain provides detailed quote and price information for the current BioNTech SE option contracts. It shows all of BioNTech's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
BioNTech option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in BioNTech's lending market. For example, when BioNTech's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on BioNTech, he or she must hedge the risk by shorting BioNTech stock over its option's life.
2024-05-17
The chart above shows BioNTech's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. BioNTech's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for BioNTech's option, there is no secondary market available for investors to trade.
BioNTech Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as BioNTech close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
BioNTech's stock options are financial instruments that give investors the right to buy or sell shares of BioNTech SE common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell BioNTech stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If BioNTech's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Please note that buying 'in-the-money' options on BioNTech lessens the impact of time decay, as they carry both intrinsic and time value. So, even if BioNTech's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money BioNTech contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if BioNTech Stock moves the wrong way.
At this time, BioNTech's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 24.2 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 185.2 M in 2024. BioNTech SE In The Money Call Balance
When BioNTech's strike price is surpassing the current stock price, the option contract against BioNTech SE stock is said to be in the money. When it comes to buying BioNTech's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on BioNTech SE are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
BioNTech Current Options Market Mood
BioNTech's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps BioNTech Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of BioNTech's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. BioNTech's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current BioNTech's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current BioNTech contract
Base on the Rule 16, the options market is currently suggesting that BioNTech SE will have an average daily up or down price movement of about 2.27% per day over the life of the 2024-05-17 option contract. With BioNTech trading at USD 88.09, that is roughly USD 2.0. If you think that the market is fully incorporating BioNTech's daily price movement you should consider buying BioNTech SE options at the current volatility level of 36.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
BioNTech |
Purchasing BioNTech options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" BioNTech calls. Remember, the seller must deliver BioNTech SE stock to the call owner when a call is exercised.
BioNTech Option Chain
When BioNTech's strike price is surpassing the current stock price, the option contract against BioNTech SE stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
BioNTech's option chain is a display of a range of information that helps investors for ways to trade options on BioNTech. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for BioNTech. It also shows strike prices and maturity days for a BioNTech against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $50.0 | 0.9734 | 0.002 | 0 | 2024-05-17 | 36.7 - 40.6 | 0.0 | In |
Call | 2024-05-17 CALL at $55.0 | 0.9603 | 0.0032 | 0 | 2024-05-17 | 31.8 - 35.7 | 0.0 | In |
Call | 2024-05-17 CALL at $60.0 | 0.9593 | 0.004 | 0 | 2024-05-17 | 26.7 - 30.7 | 0.0 | In |
Call | 2024-05-17 CALL at $65.0 | 0.964 | 0.0047 | 0 | 2024-05-17 | 21.8 - 25.4 | 0.0 | In |
Call | 2024-05-17 CALL at $70.0 | 0.9135 | 0.0096 | 0 | 2024-05-17 | 17.1 - 20.8 | 0.0 | In |
Call | 2024-05-17 CALL at $75.0 | 0.8963 | 0.0148 | 1 | 2024-05-17 | 12.9 - 14.9 | 15.1 | In |
Call | 2024-05-17 CALL at $77.5 | 0.8278 | 0.0194 | 0 | 2024-05-17 | 10.8 - 13.2 | 0.0 | In |
Call | 2024-05-17 CALL at $80.0 | 0.8088 | 0.0256 | 7 | 2024-05-17 | 8.9 - 9.9 | 8.83 | In |
Call | 2024-05-17 CALL at $82.5 | 0.7345 | 0.0317 | 4 | 2024-05-17 | 6.6 - 8.3 | 5.97 | In |
Call | 2024-05-17 CALL at $85.0 | 0.6511 | 0.0385 | 5 | 2024-05-17 | 5.1 - 6.0 | 4.23 | In |
Call | 2024-05-17 CALL at $87.5 | 0.548 | 0.044 | 5439 | 2024-05-17 | 3.7 - 4.1 | 2.5 | In |
Call | 2024-05-17 CALL at $90.0 | 0.4324 | 0.0457 | 888 | 2024-05-17 | 2.5 - 2.75 | 2.6 | Out |
Call | 2024-05-17 CALL at $92.5 | 0.3124 | 0.0438 | 437 | 2024-05-17 | 1.45 - 1.7 | 1.55 | Out |
Call | 2024-05-17 CALL at $95.0 | 0.2213 | 0.0362 | 1858 | 2024-05-17 | 0.9 - 1.05 | 1.0 | Out |
Call | 2024-05-17 CALL at $97.5 | 0.1402 | 0.0278 | 179 | 2024-05-17 | 0.4 - 0.65 | 0.55 | Out |
Call | 2024-05-17 CALL at $100.0 | 0.0757 | 0.0187 | 1875 | 2024-05-17 | 0.25 - 0.35 | 0.25 | Out |
Call | 2024-05-17 CALL at $105.0 | 0.0273 | 0.0079 | 124 | 2024-05-17 | 0.0 - 0.15 | 0.08 | Out |
Put | 2024-05-17 PUT at $140.0 | -0.869 | 0.0066 | 0 | 2024-05-17 | 49.5 - 53.4 | 0.0 | In |
Put | 2024-05-17 PUT at $135.0 | -0.8549 | 0.0073 | 0 | 2024-05-17 | 44.5 - 48.6 | 0.0 | In |
Put | 2024-05-17 PUT at $130.0 | -0.8494 | 0.008 | 0 | 2024-05-17 | 39.5 - 43.6 | 0.0 | In |
Put | 2024-05-17 PUT at $125.0 | -0.8378 | 0.0089 | 0 | 2024-05-17 | 34.4 - 38.7 | 0.0 | In |
Put | 2024-05-17 PUT at $120.0 | -0.8295 | 0.01 | 0 | 2024-05-17 | 29.5 - 33.7 | 0.0 | In |
Put | 2024-05-17 PUT at $115.0 | -0.8243 | 0.0114 | 0 | 2024-05-17 | 24.5 - 28.6 | 0.0 | In |
Put | 2024-05-17 PUT at $110.0 | -0.8291 | 0.0135 | 0 | 2024-05-17 | 19.6 - 23.3 | 0.0 | In |
Put | 2024-05-17 PUT at $105.0 | -0.842 | 0.0166 | 0 | 2024-05-17 | 14.6 - 17.9 | 18.4 | In |
Put | 2024-05-17 PUT at $100.0 | -0.9267 | 0.0175 | 0 | 2024-05-17 | 10.7 - 12.1 | 0.0 | In |
Put | 2024-05-17 PUT at $97.5 | -0.8865 | 0.026 | 6 | 2024-05-17 | 8.8 - 10.7 | 9.4 | In |
Put | 2024-05-17 PUT at $95.0 | -0.8588 | 0.0364 | 285 | 2024-05-17 | 6.6 - 8.0 | 9.6 | In |
Put | 2024-05-17 PUT at $92.5 | -0.7382 | 0.0507 | 20 | 2024-05-17 | 5.1 - 5.6 | 7.3 | In |
Put | 2024-05-17 PUT at $90.0 | -0.5893 | 0.0554 | 407 | 2024-05-17 | 3.7 - 4.0 | 4.37 | In |
Put | 2024-05-17 PUT at $87.5 | -0.4486 | 0.0554 | 190 | 2024-05-17 | 2.4 - 2.65 | 2.36 | Out |
Put | 2024-05-17 PUT at $85.0 | -0.3168 | 0.0484 | 350 | 2024-05-17 | 1.4 - 1.75 | 1.25 | Out |
Put | 2024-05-17 PUT at $82.5 | -0.2103 | 0.0377 | 123 | 2024-05-17 | 0.8 - 1.05 | 0.95 | Out |
Put | 2024-05-17 PUT at $80.0 | -0.1293 | 0.0267 | 527 | 2024-05-17 | 0.4 - 0.6 | 0.53 | Out |
Put | 2024-05-17 PUT at $77.5 | -0.0735 | 0.0172 | 1 | 2024-05-17 | 0.2 - 0.35 | 0.3 | Out |
Put | 2024-05-17 PUT at $70.0 | -0.0357 | 0.0067 | 17 | 2024-05-17 | 0.05 - 0.3 | 0.11 | Out |
BioNTech Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
BioNTech Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
BioNTech Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioNTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
BioNTech Corporate Management
Elected by the shareholders, the BioNTech's board of directors comprises two types of representatives: BioNTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioNTech. The board's role is to monitor BioNTech's management team and ensure that shareholders' interests are well served. BioNTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioNTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katalin Kariko | Senior Therapies | Profile | |
| Jens Holstein | CFO Board | Profile | |
| Sylke Maas | Vice Strategy | Profile | |
| Michael Boehler | MD Communications | Profile | |
| Siegbert Kloos | Datand Digital | Profile | |
| Sierk Poetting | COO MD | Profile |
Already Invested in BioNTech SE?
The danger of trading BioNTech SE is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BioNTech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BioNTech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BioNTech SE is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share 4.08 | Revenue Per Share 15.873 | Quarterly Revenue Growth (0.65) | Return On Assets 0.0262 |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.